{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:33:06Z","timestamp":1788413586476,"version":"build-2803163510"},"reference-count":30,"publisher":"American Society of Hematology","issue":"19","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,14]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>The utility of extracorporeal membrane oxygenation (ECMO) support for adult patients with sickle cell disease (SCD) remains poorly understood. We aimed to characterize a cohort of adult individuals with SCD in the Extracorporeal Life Support Organization (ELSO) registry who underwent venoarterial (VA) or venovenous (VV) ECMO treatment, assess clinical outcomes, and determine predictors of mortality. This multicenter, retrospective study evaluated in-hospital mortality and clinical outcomes such as bleeding and thrombotic events (BTEs) of adult patients in the ELSO registry with SCD\u2013associated International Classification of Diseases, 9th and 10th Revision, Clinical Modification codes. Post hoc multivariable logistic regression model was developed assessing predictors of mortality. Of 206 included patients, 126 and 80 received cannulation for VA ECMO or VV ECMO, respectively. Eighty-three patients (40.3%) were discharged alive; in-hospital survival was 25.5% and 61.1% for VA and VV ECMO, respectively (P &amp;lt; .001). BTEs were common during VA (45.6%) and VV (33.8%) ECMO support. There was significant increase in BTE incidence for nonsurvivors compared with survivors with VA ECMO (55.4% vs 26.5%; P &amp;lt; .001) and VV ECMO (58.1% vs 18.4%; P = .01). Male sex, increased age, pre\u2013extracorporeal life support (ECLS) cardiac arrest, cannulation for extracorporeal cardiopulmonary resuscitation (eCPR), and elevated lactate were predictive of in-hospital mortality in the VA ECMO cohort. In conclusion, in adult patients with SCD, in-hospital survival was significantly lower with VA ECMO than VV ECMO. Male sex, increased age, eCPR support, elevated lactate, and pre-ECLS arrest were strongest indicators of VA ECMO mortality. Bleeding and thrombotic complications have an association with inpatient mortality for those treated with ECMO.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025016368","type":"journal-article","created":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T19:05:26Z","timestamp":1752260726000},"page":"4881-4890","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":2,"title":["Outcomes and survival prediction in adults with sickle cell disease treated with extracorporeal membrane oxygenation"],"prefix":"10.1182","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4455-3371","authenticated-orcid":false,"given":"Alison","family":"Grazioli","sequence":"first","affiliation":[{"name":"1Division of Pulmonary and Critical Care Medicine, Department of Medicine, Program in Trauma, University of Maryland School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Plazak","sequence":"additional","affiliation":[{"name":"2Department of Pharmacy, University of Maryland Medical Center, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Willsey","sequence":"additional","affiliation":[{"name":"3University of Maryland School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Rabin","sequence":"additional","affiliation":[{"name":"4Department of Surgery and Program in Trauma, R Adams Cowley Shock Trauma Center, University of Maryland School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond P.","family":"Rector","sequence":"additional","affiliation":[{"name":"5University of Maryland Medical Center, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2880-7231","authenticated-orcid":false,"given":"Leonid","family":"Belyayev","sequence":"additional","affiliation":[{"name":"6Division of Cardiac Surgery, Department of Surgery, University of Maryland School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6609-6944","authenticated-orcid":false,"given":"Allison S.","family":"Lankford","sequence":"additional","affiliation":[{"name":"7Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Maryland School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Scalea","sequence":"additional","affiliation":[{"name":"4Department of Surgery and Program in Trauma, R Adams Cowley Shock Trauma Center, University of Maryland School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aakash","family":"Shah","sequence":"additional","affiliation":[{"name":"6Division of Cardiac Surgery, Department of Surgery, University of Maryland School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley S.","family":"Taylor","sequence":"additional","affiliation":[{"name":"6Division of Cardiac Surgery, Department of Surgery, University of Maryland School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7267-9006","authenticated-orcid":false,"given":"Mark T.","family":"Gladwin","sequence":"additional","affiliation":[{"name":"8Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"2025101409264649000_bib1","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3389\/fimmu.2020.00454","article-title":"The red blood cell-inflammation vicious circle in sickle cell disease","volume":"11","author":"Nader","year":"2020","journal-title":"Front Immunol"},{"key":"2025101409264649000_bib2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev-pathmechdis-012418-012838","article-title":"Pathophysiology of sickle cell disease","volume":"14","author":"Sundd","year":"2019","journal-title":"Annu Rev Pathol"},{"issue":"3","key":"2025101409264649000_bib3","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/ejh.14025","article-title":"Prevalence and outcomes of pulmonary embolism with sickle cell disease: analysis of the Nationwide Inpatient Sample, 2016-2020","volume":"111","author":"Ilerhunmwuwa","year":"2023","journal-title":"Eur J Haematol"},{"issue":"5","key":"2025101409264649000_bib4","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1164\/ajrccm.153.5.8630622","article-title":"Bronchoalveolar lavage in adult sickle cell patients with acute chest syndrome: value for diagnostic assessment of fat embolism","volume":"153","author":"Godeau","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"2025101409264649000_bib5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1182\/asheducation-2014.1.425","article-title":"Pulmonary hypertension in sickle cell disease: diagnosis and management","volume":"2014","author":"Ataga","year":"2014","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"3","key":"2025101409264649000_bib6","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1097\/CCM.0000000000003628","article-title":"Extracorporeal life support for severe acute chest syndrome in adult sickle cell disease: a preliminary report","volume":"47","author":"Boissier","year":"2019","journal-title":"Crit Care Med"},{"issue":"1","key":"2025101409264649000_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MAT.0000000000002038","article-title":"Adult highlights from the extracorporeal life support organization registry: 2017-2022","volume":"70","author":"Rali","year":"2024","journal-title":"ASAIO J"},{"issue":"11","key":"2025101409264649000_bib8","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1007\/s42399-021-00987-0","article-title":"ECMO therapy in acute chest syndrome for patients with sickle cell disease: a case report and literature review","volume":"3","author":"Avgeridou","year":"2021","journal-title":"SN Compr Clin Med"},{"issue":"3","key":"2025101409264649000_bib9","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1016\/j.athoracsur.2019.05.093","article-title":"Venoarterial extracorporeal membrane oxygenation in sickle cell disease for urgent cardiac surgery","volume":"109","author":"de Roux","year":"2020","journal-title":"Ann Thorac Surg"},{"issue":"9","key":"2025101409264649000_bib10","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1177\/08850666241260605","article-title":"Venoarterial extracorporeal membrane oxygenation therapy in patients with sickle cell disease: case series and review for intensive care physicians","volume":"40","author":"Grazioli","year":"2024","journal-title":"J Intensive Care Med"},{"issue":"12","key":"2025101409264649000_bib11","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.annfar.2012.10.002","article-title":"Sickle cell disease and life-threatening acute chest syndrome: interest of extracorporeal life support","volume":"31","author":"Grein","year":"2012","journal-title":"Ann Fr Anesth Reanim"},{"issue":"3","key":"2025101409264649000_bib12","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/aor.14880","article-title":"Characteristics and outcomes of children and young adults with sickle cell disease supported with extracorporeal membrane oxygenation (ECMO): an updated analysis of the ELSO registry","volume":"49","author":"Remy","year":"2024","journal-title":"Artif Organs"},{"key":"2025101409264649000_bib13","unstructured":"Extracorporeal Life Support Organization\n          . ECLS international summary of statistics. Accessed 1 August 2024. https:\/\/www.elso.org\/registry\/internationalsummaryandreports\/internationalsummary.aspx."},{"issue":"10037","key":"2025101409264649000_bib14","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1016\/S0140-6736(16)00647-4","article-title":"Cardiovascular complications and risk of death in sickle-cell disease","volume":"387","author":"Gladwin","year":"2016","journal-title":"Lancet"},{"issue":"3","key":"2025101409264649000_bib15","doi-asserted-by":"crossref","first-page":"150755","DOI":"10.1016\/j.tmrv.2023.150755","article-title":"Acute chest syndrome in sickle cell disease","volume":"37","author":"Bhasin","year":"2023","journal-title":"Transfus Med Rev"},{"issue":"4","key":"2025101409264649000_bib16","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jacc.2006.09.038","article-title":"Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease","volume":"49","author":"Sachdev","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"2025101409264649000_bib17","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1001\/jama.2012.358","article-title":"Mortality in adults with sickle cell disease and pulmonary hypertension","volume":"307","author":"Mehari","year":"2012","journal-title":"JAMA"},{"issue":"7","key":"2025101409264649000_bib18","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1097\/CCM.0000000000000316","article-title":"Outcomes of adult patients with sickle cell disease admitted to the ICU: a case series","volume":"42","author":"Cecchini","year":"2014","journal-title":"Crit Care Med"},{"issue":"9","key":"2025101409264649000_bib19","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1056\/NEJMoa035477","article-title":"Pulmonary hypertension as a risk factor for death in patients with sickle cell disease","volume":"350","author":"Gladwin","year":"2004","journal-title":"N Engl J Med"},{"issue":"7","key":"2025101409264649000_bib20","doi-asserted-by":"crossref","first-page":"e99489","DOI":"10.1371\/journal.pone.0099489","article-title":"Risk factors for death in 632 patients with sickle cell disease in the United States and United Kingdom","volume":"9","author":"Gladwin","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"2025101409264649000_bib21","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jchf.2020.09.004","article-title":"Hemocompatibility-related adverse events and survival on venoarterial extracorporeal life support: an ELSO registry analysis","volume":"8","author":"Chung","year":"2020","journal-title":"JACC Heart Fail"},{"issue":"2","key":"2025101409264649000_bib22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00134-021-06593-x","article-title":"Bleeding and thrombotic events in adults supported with venovenous extracorporeal membrane oxygenation: an ELSO registry analysis","volume":"48","author":"Nunez","year":"2022","journal-title":"Intensive Care Med"},{"issue":"18","key":"2025101409264649000_bib23","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.3390\/jcm11185375","article-title":"Bleeding and thrombotic issues during extracorporeal membrane oxygenation","volume":"11","author":"Ranucci","year":"2022","journal-title":"J Clin Med"},{"key":"2025101409264649000_bib24","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3389\/fmed.2018.00352","article-title":"Current understanding of how extracorporeal membrane oxygenators activate haemostasis and other blood components","volume":"5","author":"Doyle","year":"2018","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"2025101409264649000_bib25","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1182\/bloodadvances.2019000940","article-title":"Bleeding in patients with sickle cell disease: a population-based study","volume":"4","author":"Hariharan","year":"2020","journal-title":"Blood Adv"},{"issue":"1","key":"2025101409264649000_bib26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1182\/asheducation-2007.1.91","article-title":"Hypercoagulability in sickle cell disease: new approaches to an old problem","volume":"2007","author":"Ataga","year":"2007","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"3","key":"2025101409264649000_bib27","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1172\/JCI89741","article-title":"Intravascular hemolysis and the pathophysiology of sickle cell disease","volume":"127","author":"Kato","year":"2017","journal-title":"J Clin Invest"},{"issue":"6","key":"2025101409264649000_bib28","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1164\/rccm.201401-0065ST","article-title":"An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease","volume":"189","author":"Klings","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"2025101409264649000_bib29","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1182\/blood-2015-08-618561","article-title":"Pathophysiology and treatment of pulmonary hypertension in sickle cell disease","volume":"127","author":"Gordeuk","year":"2016","journal-title":"Blood"},{"issue":"4","key":"2025101409264649000_bib30","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3324\/haematol.2016.153791","article-title":"Risk factors for mortality in adult patients with sickle cell disease: a meta-analysis of studies in North America and Europe","volume":"102","author":"Maitra","year":"2017","journal-title":"Haematologica"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/19\/4881\/2414128\/blooda_adv-2025-016368-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/19\/4881\/2414128\/blooda_adv-2025-016368-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T13:27:33Z","timestamp":1760448453000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/9\/19\/4881\/546156\/Outcomes-and-survival-prediction-in-adults-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":30,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2025,10,14]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025016368","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10,14]]},"published":{"date-parts":[[2025,9,26]]}}}